My Name Is Rachel Corrie to Be Published by TCG in Fall | Playbill

Related Articles
News My Name Is Rachel Corrie to Be Published by TCG in Fall The acclaimed, and controversial historical solo play My Name Is Rachel Corrie will be published in the U.S. by TCG in September.

The Royal Court Theatre production of My Name Is Rachel Corrie will begin performances at Off-Broadway's Minetta Lane Theatre Oct. 15. The limited engagement will play 48 performances through Nov. 19.

The play, which is taken from the writings of the late American activist Rachel Corrie, will be directed by actor Alan Rickman, who, with journalist Katharine Viner, edited Corrie's writings.

The TCG printing will run 64 pages and is priced at $12.95.

The play opened in April 2005 at London's Royal Court Theatre and returned for an encore engagement in October 2005. It later played nine weeks at London's Playhouse Theatre in spring 2006. The play was nominated for an Olivier Award for Outstanding Achievement.

The work became the subject of a heated debate this past spring when it was scheduled and then postponed at Off-Broadway's New York Theatre Workshop. Both NYTW and the Royal Court were thrust into a press-statement war immediately after the decision to delay the work; the London-based company and the play's creators accusing the New York company of censorship while the New York troupe stating it merely sought to present the play in a climate suitable for the volatile work. My Name Is Rachel Corrie, according to press notes, "chronicles the human, social and political evolution in the life and controversial death of a young woman. The play traces the life of Rachel from her early days in Washington State through her experiences as an activist seeking to learn more about the community within Gaza." Corrie was a 23-year-old protester who was killed by an Israeli bulldozer.

 
RELATED:
Today’s Most Popular News:
 X

Blocking belongs
on the stage,
not on websites.

Our website is made possible by
displaying online advertisements to our visitors.

Please consider supporting us by
whitelisting playbill.com with your ad blocker.
Thank you!